A polyvalent DNA prime with matched polyvalent proteinGLASE boost regimen elicited the most robust and broad lgG and V1V2 binding antibody and antibody and CV4 T cell responses among 13 HIV vaccine trials

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By